BrandPost: Expanding the Boundaries of Precision Medicine with HPC

Genomic sequencing and analysis has emerged as one of the new keys to fighting a wide range of diseases. It’s increasingly used to drive precision medicine that tailors the treatment to the genetic makeup of the patient. It’s also used to identify patients who are predisposed to certain diseases and to identify patients who might have an adverse reaction to certain drugs.

This is all in a day’s work for the researchers at the Garvan Institute of Medical Research, one of Australia’s largest medical research institutions. The institute is on a mission to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health. Garvan’s research focuses on some of the most critical areas in healthcare, including cancer, diabetes and metabolism, genomics and epigenetics, immunology and inflammation, osteoporosis and bone biology, and neuroscience.

To read this article in full, please click here